共 50 条
- [1] Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain MetastasesCLINICAL CANCER RESEARCH, 2023, 29 (01) : 174 - 182Kabraji, SheheryarNi, JingSammons, SarahLi, TianyuVan Swearingen, Amanda E. D.Wang, YanzhiPereslete, AlyssaHsu, LianggeDiPiro, Pamela J.Lascola, ChrisMoore, HeatherHughes, MelissaRaghavendra, Akshara S.Gule-Monroe, MariaMurthy, Rashmi K.Winer, Eric P.Anders, Carey K.Zhao, Jean J.Lin, Nancy U.
- [2] Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab DeruxtecanNPJ PRECISION ONCOLOGY, 2025, 9 (01)Fabi, AlessandraRossi, AlessandroCaputo, RobertaPisegna, SimonaScagnoli, SimonePantano, FrancescoD'Auria, GiulianaFedele, PalmaFabbri, AgneseVernieri, ClaudioPalleschi, MichelaCarbognin, LuisaFerretti, GianluigiDi Monte, ElenaParis, IdaPavese, FrancescoGarrone, OrnellaFranco, AntonioDe Laurentiis, MichelinoFranceschini, GianlucaScambia, GiovanniGiannarelli, DianaMasetti, RiccardoBotticelli, Andrea
- [3] Trastuzumab deruxtecan in patients with breast cancer with brain metastases: The DE-REAL studyJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)Botticelli, AndreaFabi, AlessandraRossi, AlessandroCaputo, RobertaPisegna, SimonaPantano, FrancescoD'Auria, GiulianaCarbognin, LuisaFedele, PalmaFabbri, AgneseVernieri, ClaudioPalleschi, MichelaFerretti, GianluigiParis, IdaDi Monte, ElenaPavese, FrancescoGarrone, OrnellaGiannarelli, DianaDe laurentiis, MichelinoScambia, Giovanni
- [4] Preclinical and early clinical data of ZN-1041 in combination with trastuzumab deruxtecan to treat breast cancer with or without CNS metastasesJOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)Anders, Carey K.Lin, Nancy U.Chand, AartiFu, TingtingZhu, DiWang, ZhengZhou, DingCheng, Ziqiang
- [5] Trastuzumab Deruxtecan for Breast CancerNEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2346 - 2347Zheng, FangchaoDu, FengYuan, Peng
- [6] Trastuzumab deruxtecan in breast cancerCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 198Martin, MiguelPandiella, AtanasioVargas-Castrillon, EmilioDiaz-Rodriguez, ElenaIglesias-Hernangomez, TeresaCano, Concha MartinezFernandez-Cuesta, InesWinkow, ElenaPerello, Maria Francesca
- [7] LCCC 1025: Phase II study of everolimus, trastuzumab, and vinorelbine for HER2+breast cancer brain metastases (BCBM).JOURNAL OF CLINICAL ONCOLOGY, 2017, 35Anders, Carey K.Deal, Allison MaryVan Swearingen, Amanda Elyse DaySiegel, MarniHayes, David N.Jo, HeejoonLittle, PaulDees, Elizabeth ClaireMuss, Hyman B.Jolly, Trevor AugustusZagar, TimothySmith, J. KeithFisher, Julie GottliebShah, Nikita C.Nabell, LisleNanda, RitaDillon, Patrick MichaelPuhalla, ShannonAbramson, Vandana GuptaCarey, Lisa A.
- [8] Trastuzumab Deruxtecan for Breast Cancer REPLYNEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (24): : 2347 - 2347Cortes, JavierIm, Seock-AhCathcart, Jillian
- [9] A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM)JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Leone, Jose PabloHu, JianiBarry, William ThomasDuda, Dan G.Gerstner, Elizabeth RobinsJain, Rakesh K.Tan, SallyLawler, Elizabeth S.Winer, Eric P.Lin, Nancy U.Tolaney, Sara M.
- [10] The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patientsda multicenter real-world analysisESMO OPEN, 2024, 9 (05)Dannehl, D.Jakob, D.Mergel, F.Estler, A.Engler, T.Volmer, L.Frevert, M-LMatovina, S.Englisch, A.Tegeler, C. M.Rohner, A.Seller, A.Hahn, M.Pfister, K.Fink, A.Popp, I.Lorenz, S.Tabatabai, G.Juhasz-Boess, I.Janni, W.Brucker, S.Taran, F. -AHartkopf, A.Schaeffler, H.